<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04776421</url>
  </required_header>
  <id_info>
    <org_study_id>STARS-RC02</org_study_id>
    <nct_id>NCT04776421</nct_id>
  </id_info>
  <brief_title>Diverting Ileostomy and Anal Functional Outcomes After Anus Preservation Surgery</brief_title>
  <official_title>A Prospective Registration Study on Diverting Ileostomy and Anal Functional Outcomes After Anus Preservation Surgery in Middle and Low Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analyze the occurrence of complications, rectal function and quality of life after&#xD;
      anus-preserving surgery for middle and low rectal cancer, so as to evaluate the role of&#xD;
      protective ileostomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>comprehensive complication index</measure>
    <time_frame>1 year</time_frame>
    <description>comprehensive complication index, CCI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>1 year</time_frame>
    <description>Postoperative complications based on Clavien-Dindo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of anastomotic leakage</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of anastomotic stenosis</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stoma-related complications</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications related to ileostomy reversal</measure>
    <time_frame>three months after ileostomy reversal</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>three years after the operation</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Diverting Ileostomy</condition>
  <condition>Middle and Low Rectal Cancer</condition>
  <condition>Functional Outcome</condition>
  <condition>Stoma Complications</condition>
  <arm_group>
    <arm_group_label>ileostomy group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Diverting ileostomy</intervention_name>
    <description>Diverting ileostomy</description>
    <arm_group_label>ileostomy group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Middle and low rectal cancer patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Necessary conditions: meet one of the following conditions&#xD;
&#xD;
          1. Difficult pelvis: narrow pelvis (diameter of ischial tuberosity &lt;10 cm, diameter of&#xD;
             ischial spine &lt;12 cm) 13 or BMI≥30kg/m2 or tumor diameter≥5cm2.&#xD;
&#xD;
          2. To receive treatment before surgery: preoperative neoadjuvant radiotherapy or&#xD;
             concurrent chemoradiation or ESD&#xD;
&#xD;
          3. The anastomosis is below the level of the levator ani muscle: such as ISR, TaTME&#xD;
             surgery, etc.&#xD;
&#xD;
        Other conditions:&#xD;
&#xD;
          1. Age: 18 to 75 years old, male or female;&#xD;
&#xD;
          2. Preoperative biopsy pathological diagnosis of rectal adenocarcinoma;&#xD;
&#xD;
          3. Received MRI evaluation before surgery, and the distance between the lower edge of the&#xD;
             tumor and the anal edge is no more than 10cm;&#xD;
&#xD;
          4. The clinical stage is T1-3N0-2M0;&#xD;
&#xD;
          5. Undertake elective laparoscopic TME for colon-rectal or colon-anal anastomosis&#xD;
&#xD;
          6. ECOG score 0-2;&#xD;
&#xD;
          7. Heart, lung, liver, and kidney functions can tolerate surgery;&#xD;
&#xD;
          8. Patients and their families can understand and are willing to participate in this&#xD;
             clinical study, and sign informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Past history of malignant colorectal tumors or recent diagnosis combined with other&#xD;
             malignant tumors;&#xD;
&#xD;
          2. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding,&#xD;
             etc. who need emergency surgery;&#xD;
&#xD;
          3. Neighboring organs need to be combined with organ removal&#xD;
&#xD;
          4. ASA grade ≥ grade IV and/or ECOG physical status score&gt; 2 points;&#xD;
&#xD;
          5. Those who have severe liver and kidney function, cardiopulmonary function, blood&#xD;
             coagulation dysfunction, or combined with serious underlying diseases that cannot&#xD;
             tolerate surgery;&#xD;
&#xD;
          6. Have a history of severe mental illness;&#xD;
&#xD;
          7. Pregnant or lactating women;&#xD;
&#xD;
          8. Those with a history of taking hormone drugs;&#xD;
&#xD;
          9. Patients with other clinical and laboratory conditions considered by the investigator&#xD;
             should not participate in the trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Quan Wang, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jilin University First Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Quan Wang, Prof.</last_name>
    <phone>+86-431-81875602</phone>
    <email>wquan@jlu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Weihua Tong</last_name>
    <phone>+86-431-81875602</phone>
    <email>tongwh@jlu.edu.cn</email>
  </overall_contact_backup>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 24, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Quan Wang</investigator_full_name>
    <investigator_title>Head of Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

